John Paulson Teva Pharmaceutical Industries LTD Transaction History

Paulson & Co. Inc.

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2017 Feb 14, 2018	SELL	$11.23 - $19.1 $27.5 Million - $46.8 Million	-2,450,000 Closed	0 $0
Q3 2017 Nov 14, 2017	SELL	$15.41 - $32.17 $66.2 Million - $138 Million	-4,294,000 Reduced 63.67%	2,450,000 $43.1 Million
Q2 2017 Sep 20, 2017	BUY	N/A	6,744,000	6,744,000 $224 Million

640

580M

19.6M

6.77M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.1B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Paulson & Co. Inc., based on Form 13F filings with the SEC.

Stay updated on Paulson & Co. Inc. and John Paulson with notifications on news.